Amanta Healthcare Limited promoter Bhavesh Girishbhai Patel increased his shareholding in the company through a market purchase on June 17, 2026. The acquisition of 4,635 equity shares raised his total stake to 16.31%, reflecting a consolidation of promoter confidence in the pharmaceutical entity.

Transaction Details

The transaction was executed on the National Stock Exchange (NSE) as a market purchase. According to the disclosure filed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the shares were bought at a total transaction value of ₹6,96,730, excluding taxes and brokerage.

Post-Transaction Holding

Following the acquisition, Bhavesh Girishbhai Patel holds a total of 63,31,179 equity shares. This represents 16.31% of the company's paid-up share capital, up from the previous holding of 63,26,544 shares or 16.29%.

Amanta Healthcare Limited disclosed that Kirit Ambalal Desai, a member of its promoter group, sold 5,000 equity shares through an open market transaction on June 15, 2026. The sale reduced his shareholding in the company to 2.91%, a move that was formally intimated to the management on June 17, 2026. This transaction was executed on the National Stock Exchange (NSE) and is part of the regulatory disclosures required under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The shares were sold at a total value of Rs 7,86,550. Prior to this disposal, Desai held 11,33,079 equity shares, which accounted for 2.92% of the company's paid-up share capital. Following the transaction, his holding has adjusted to 11,28,079 equity shares. The company confirmed that no trading activity was reported in the derivatives segment by the promoter group member during this period.

Transaction Details

The disclosure was submitted in Form C to the stock exchanges, outlining the specifics of the acquisition and disposal of securities. The transaction was classified as a market sale, and the value provided excludes taxes, brokerage, and other associated charges.

Holding Pattern

The table below details the change in the promoter group member's shareholding before and after the transaction.

The company stated that the disclosure was made in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The filing was signed by Nikhita Dinodia, Company Secretary & Compliance Officer of Amanta Healthcare Limited.